gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ICUHealthcareSurgical Instruments

SeaStar Medical Holding Corporation Common Stock (ICU)

$2.04+2.00%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$2.00▼ 64.32% in range
Nov 3, 2025Low $2.00 · High $5.61Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

SeaStar Medical Holding closed at $2.04 on Nov 4, up 2.00%, within 2.0% of its 52-week closing low. Volume of 124.8K shares was 0.39× its 20-day average (below normal).

Split-adjusted performance: -36.1% over one month, -58.1% over six months, -63.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $615K, up 82.0% from a year earlier, with a net margin of -606.5%.

Short interest was 185.8K shares at the Oct 15 settlement, up 29.3% from the prior report (4.2% of float, 1.0 days to cover).

Market cap$10.8M5.3M shares
Revenue · quarter$615.0K+82.0% YoY
Diluted EPS$-0.91—
P/E · TTM—P/S 6.3×
Net margin-606.5%Gross 91.2%
Dividend yieldNone
52-week range2.00 – 5.61−63.6% from high
Volume124.8K0.39× 20-day avg
Volatility · 60d117.0%Annualised
Short % of float4.2%1.0 days to cover
Net cash$6.8MCash $7.0M
Next earnings—Not scheduled
Split-adjusted performance
1W −17.7%1M −36.1%3M −33.1%6M −58.1%YTD −15.0%1Y −63.6%3Y −99.2%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum19
Revenue growth97
Net margin9
Value (low P/E)—
Size16

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short185.8K+29.3% vs prior
Days to cover1.0Settled Oct 15
% of float4.2%
Short vol. 10d42.2%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ICUSeaStar Medical Holding$2.04+2.00%−58.1%+82.0%−606.5%—$10.8M
FEMYFemasys$1.44+2.86%−84.1%−18.9%−1346.8%—$12.1MCompare
SINTSiNtx Technologies$1.66−3.49%−30.8%+199.3%−803.5%—$12.5MCompare
GUTSFractyl Health$0.9725+8.27%−89.0%———$12.9MCompare
PAVMPAVmed$1.66−8.79%−76.3%+450.0%−16603.0%—$13.3MCompare
NMTCNeuroOne Medical Technologies$0.9500−3.06%−77.9%+16.3%−101.7%—$8.7MCompare
CTSOCytosorbents$4.56+0.44%−60.0%+0.2%−45.9%—$14.4MCompare
MODDModular Medical$1.67−5.65%−57.3%———$15.9MCompare
PMIPicard Medical$7.19−7.58%−38.0%—−191.6%—$16.8MCompare

News about SeaStar Medical Holding

All news →

No recent articles focused on SeaStar Medical Holding.

Quick answers

What does SeaStar Medical Holding do?
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
What is ICU's market cap?
$10.84M, based on the Nov 4 close of $2.04.
Does SeaStar Medical Holding pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ICU is sold short?
185.8K shares, 4.2% of float, as of Oct 15, 2026.
What sector is ICU in?
Healthcare, in the Surgical Instruments industry.

About SeaStar Medical Holding

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

HQ: Denver, CO17 employeesListed Oct 31, 2022seastarmedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology